{
    "nctId": "NCT04197856",
    "briefTitle": "Direct Information to At-risk Relatives",
    "officialTitle": "Direct Letters to Relatives at Risk of Hereditary Cancer- a Multi-centre Randomised Controlled Trial of Healthcare-assisted Versus Family-mediated Risk Disclosure at Swedish Cancer Genetics Clinics (DIRECT-study)",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Familial Breast Cancer, Familial Colorectal Cancer, Hereditary Breast and Ovarian Cancer Syndrome, Hereditary Breast Cancer, Lynch Syndrome",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SCREENING",
    "enrollmentCount": 490,
    "primaryOutcomeMeasure": "Uptake of genetic counselling among the patient's at-risk relatives",
    "eligibilityCriteria": "Inclusion criteria\n\n1. Patient being offered a cancer genetic investigation for hereditary breast, ovarian or colorectal cancer.\n2. Written consent to participate the study,\n3. Belonging to a family with; a) familial breast cancer, b) familial colorectal cancer, c) pathogenic variant in PALB2, BRCA1/2 (Hereditary breast cancer, hereditary breast and ovarian cancer), MLH1, MSH2, MSH6, PMS2 (Lynch syndrome) and\n4. Having at least one eligible at-risk relative (family member deemed to be an ARR recommended genetic counseling within a year).\n\nExclusion Criteria:\n\n1. Cannot convey personal opinions and preferences by themselves.\n2. No eligible at-risk relatives living in Sweden.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}